Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pertuzumab as second‑ or later‑line therapy for human epidermal growth factor receptor 2‑positive metastatic breast cancer: A clinical experience.
Biskup E, Sartorius CM, Müller A, Leo C, Nussbaum CU, Georgescu Margarint EL, Koychev D, Schreiber A, Taverna C, Thorn D, Vetter M. Biskup E, et al. Among authors: vetter m. Mol Clin Oncol. 2023 May 18;19(1):52. doi: 10.3892/mco.2023.2648. eCollection 2023 Jul. Mol Clin Oncol. 2023. PMID: 37303973 Free PMC article.
SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients.
Vetter M, Rothgiesser KM, Li Q, Hawle H, Schönfeld W, Ribi K, Riniker S, von Moos R, Trojan A, Kralidis E, Fehr M, Müller A, Thürlimann B; Swiss Group for Clinical Cancer Research (SAKK). Vetter M, et al. Endocr Oncol. 2022 Feb 10;2(1):9-18. doi: 10.1530/EO-21-0009. eCollection 2022 Jan. Endocr Oncol. 2022. PMID: 37435469 Free PMC article.
425 results